Laurie J. Hall Trustee’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-40
Closed -$5K 311
2022
Q4
$5K Sell
40
-20
-33% -$2.32K ﹤0.01% 260
2022
Q3
$7K Sell
60
-25
-29% -$2.52K ﹤0.01% 268
2022
Q2
$6K Hold
85
﹤0.01% 284
2022
Q1
$7K Hold
85
﹤0.01% 288
2021
Q4
$8K Hold
85
﹤0.01% 285
2021
Q3
$8K Sell
85
-50
-37% -$3.85K ﹤0.01% 286
2021
Q2
$10K Hold
135
﹤0.01% 285
2021
Q1
$10K Buy
135
+60
+80% +$5.54K ﹤0.01% 289
2020
Q4
$13K Hold
75
0.01% 275
2020
Q3
$11K Buy
+75
New +$11.4K ﹤0.01% 267
2019
Q4
$7K Buy
55
+10
+22% +$1.01K ﹤0.01% 286
2019
Q3
$3K Sell
45
-25
-36% -$2.95K ﹤0.01% 306
2019
Q2
$11K Sell
70
-10
-13% -$1.22K 0.01% 264
2019
Q1
$10K Hold
80
0.01% 272
2018
Q4
$11K Sell
80
-10
-11% -$1.25K 0.01% 265
2018
Q3
$15K Hold
90
0.01% 272
2018
Q2
$121K Hold
90
0.07% 139
2018
Q1
$7K Sell
90
-3,200
-97% -$213K ﹤0.01% 309
2017
Q4
$224K Buy
3,290
+3,160
+2,431% +$167K 0.13% 98
2017
Q3
$5.9K Hold
130
﹤0.01% 275
2017
Q2
$4.38K Hold
130
﹤0.01% 282
2017
Q1
$3.8K Buy
+130
New +$4.02K ﹤0.01% 289

Other funds holding SRPT

Laurie J. Hall Trustee's SRPT Position: Q1 2023 in Review

Laurie J. Hall Trustee sold out of Sarepta Therapeutics (SRPT) in Q1 2023, closing a stake of 40 shares — an estimated $5K sold.

Laurie J. Hall Trustee first reported a position in SRPT in Q1 2017 and held it in 22 quarters. The position peaked at $224K in Q4 2017. 425 funds tracked by Wall St. Rank hold SRPT as of Q1 2023.

  • Laurie J. Hall Trustee reported no remaining Sarepta Therapeutics position as of Q1 2023 after selling out during the quarter.
  • Laurie J. Hall Trustee sold 40 Sarepta Therapeutics shares in Q1 2023, an estimated $5K.
  • Laurie J. Hall Trustee first reported a position in Sarepta Therapeutics in Q1 2017 and held it in 22 quarters.
  • Laurie J. Hall Trustee's Sarepta Therapeutics position peaked at $224K in Q4 2017.
  • 425 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2023.

Based on Laurie J. Hall Trustee's 13F filing for Q1 2023, filed 7 Apr 2023.